| Cancer regression in patients after transfer of genetically engineered lymphocytes RA Morgan, ME Dudley, JR Wunderlich, MS Hughes, JC Yang, ... Science 314 (5796), 126-129, 2006 | 3868 | 2006 |
| Cancer immunotherapy: moving beyond current vaccines SA Rosenberg, JC Yang, NP Restifo Nature medicine 10 (9), 909-915, 2004 | 3622 | 2004 |
| Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes ME Dudley, JR Wunderlich, PF Robbins, JC Yang, P Hwu, ... Science 298 (5594), 850-854, 2002 | 3580 | 2002 |
| Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapycomplete regressions in melanoma SA Rosenberg, JC Yang, RM Sherry, US Kammula, MS Hughes, ... Clinical cancer research 17 (13), 4550-4557, 2011 | 2408 | 2011 |
| Adoptive cell transfer as personalized immunotherapy for human cancer SA Rosenberg, NP Restifo Science 348 (6230), 62-68, 2015 | 2238 | 2015 |
| Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma SA Rosenberg, JC Yang, DJ Schwartzentruber, P Hwu, FM Marincola, ... Nature medicine 4 (3), 321-327, 1998 | 2215 | 1998 |
| Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma ME Dudley, JR Wunderlich, JC Yang, RM Sherry, SL Topalian, NP Restifo, ... Journal of clinical oncology: official journal of the American Society of …, 2005 | 2035 | 2005 |
| Adoptive cell transfer: a clinical path to effective cancer immunotherapy SA Rosenberg, NP Restifo, JC Yang, RA Morgan, ME Dudley Nature Reviews Cancer 8 (4), 299-308, 2008 | 1951 | 2008 |
| Adoptive immunotherapy for cancer: harnessing the T cell response NP Restifo, ME Dudley, SA Rosenberg Nature Reviews Immunology 12 (4), 269-281, 2012 | 1911 | 2012 |
| Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma GQ Phan, JC Yang, RM Sherry, P Hwu, SL Topalian, ... Proceedings of the National Academy of Sciences 100 (14), 8372-8377, 2003 | 1871 | 2003 |
| A human memory T cell subset with stem cell–like properties L Gattinoni, E Lugli, Y Ji, Z Pos, CM Paulos, MF Quigley, JR Almeida, ... Nature medicine 17 (10), 1290-1297, 2011 | 1851 | 2011 |
| Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1 PF Robbins, RA Morgan, SA Feldman, JC Yang, RM Sherry, ME Dudley, ... Journal of Clinical Oncology 29 (7), 917, 2011 | 1800 | 2011 |
| Adoptive immunotherapy for cancer: building on success L Gattinoni, DJ Powell Jr, SA Rosenberg, NP Restifo Nature Reviews Immunology 6 (5), 383-393, 2006 | 1777 | 2006 |
| Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen LA Johnson, RA Morgan, ME Dudley, L Cassard, JC Yang, MS Hughes, ... Blood, The Journal of the American Society of Hematology 114 (3), 535-546, 2009 | 1604 | 2009 |
| Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens ME Dudley, JC Yang, R Sherry, MS Hughes, R Royal, U Kammula, ... Journal of Clinical Oncology 26 (32), 5233, 2008 | 1570 | 2008 |
| Natural selection of tumor variants in the generation of “tumor escape” phenotypes HT Khong, NP Restifo Nature immunology 3 (11), 999-1005, 2002 | 1371 | 2002 |
| Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy RA Morgan, N Chinnasamy, D Abate-Daga, A Gros, PF Robbins, Z Zheng, ... Journal of immunotherapy 36 (2), 133-151, 2013 | 1183 | 2013 |
| Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells L Gattinoni, SE Finkelstein, CA Klebanoff, PA Antony, DC Palmer, ... The Journal of experimental medicine 202 (7), 907-912, 2005 | 1139 | 2005 |
| Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells L Gattinoni, CA Klebanoff, DC Palmer, C Wrzesinski, K Kerstann, Z Yu, ... The Journal of clinical investigation 115 (6), 1616-1626, 2005 | 1120 | 2005 |
| Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti–cytotoxic T-lymphocyte antigen-4 P Attia, GQ Phan, AV Maker, MR Robinson, MM Quezado, JC Yang, ... Journal of clinical oncology: official journal of the American Society of …, 2005 | 1117 | 2005 |
Steven A RosenbergNCIVerified email at nih.gov
